课题基金基金详情
LincR-PPP2R5C编码的微肽TREMP调控CD4+T细胞分化介导哮喘发生发展的机制研究
结题报告
批准号:
81970031
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
黄茂
依托单位:
学科分类:
支气管哮喘
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
黄茂
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
长链非编码RNA(lncRNA)编码的微肽在哮喘中作用未知。我们前期发现LincR-PPP2R5C的短开放阅读框架6(sORF6)可以编码微肽,促进Th2分化;体内转染sORF6后哮喘加重,2型细胞因子增多;LincR-PPP2R5C-sORF6暂命名为T细胞调控微肽(TREMP);TREMP与哺乳动物雷帕霉素靶蛋白(mTOR)同源;TREMP过表达影响mTOR通路;质谱分析提示TREMP可结合细胞骨架相关蛋白4 (CKAP4);CAKP4激活mTOR通路并促进IL-33分泌。我们推测:TREMP结合CAKP4调控mTOR通路、增加IL-33表达从而促进Th2分化,介导过敏性哮喘的发生发展。本项目拟构建病毒载体、全敲除和CD4+T细胞条件性敲除小鼠以及TREMP单克隆抗体等,考察TREMP在哮喘发生发展中的作用。上述研究能加深理解lncRNA的编码潜能以及CD4+T细胞在哮喘中的分化机制。
英文摘要
Roles of micropeptide encoded by long non-coding RNA (lncRNA) in the differentiation of CD4+T cells from allergic asthma remain largely elusive. In preliminary experiments, LincR-PPP2R5C contributed to CD4+ T cells differentiation in allergic asthma. The short Open Reading Frame 6 (sORF6) from LincR-PPP2R5C encodes a micropeptide, which regulates the T cells differentiation. We name sORF6 micropeptide TREMP (T cell regulatory micropeptide). In vitro, TREMP promotes Th2 differentiation. In vivo, TREMP aggravates asthma and type 2 cytokines in the mouse model of acute asthma. TREMP shares evolutionary similarity with mammalian target of Rapamycin (mTOR). In vitro and in vivo, TREMP over-expression affects the mTOR pathway. Mass Spectrometry analysis reveals that TREMP may interact with Cytoskeleton-associated protein 4 ( CKAP4), which activates mTOR pathway and increases IL-33 secretion. Therefore, we postulate the hypothesis that LincR-PPP2R5C encodes micropeptide TREMP may regulate the Th2 differentiation via CKAP4-mTOR-IL-33 in allergic asthma. To explore the above hypothesis, we would (1) construct lentivirus system, which aims to over-expressing or silencing TREMP in the CD4+ T cells; (2) knockout TREMP in the mouse or conditionally knockout TREMP in the CD4+ T cells in vivo; (3) produce TREMP monoclonal antibody and test its function in the CD4+T cells differentiation and asthma. Our work would of great value in the exploring the roles of lncRNA encodes novel micropeptide in the differentiation of CD4+ T cells in allergic asthma.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1186/s12890-022-01956-6
发表时间:2022-04-24
期刊:BMC pulmonary medicine
影响因子:3.1
作者:
通讯作者:
DOI:10.1111/imj.14685
发表时间:2019-11
期刊:Internal Medicine Journal
影响因子:2.1
作者:Wen-Qing Yu;Ning-Fei Ji;Ming-Dong Ding;Yuan Ma;Da-Ming Zhou;Yan Chen;Zhu Yang;Zhen-Zhen Wu;Cheng-Jing Gu;Gui-Hong Dai;Rong-Rong Jin;Jian-Chun Xian;Chao-Jie Wu;Yan-Li Wang;Yi-Bin Tan;Hong-Tao Xu;Mao Huang
通讯作者:Mao Huang
DOI:--
发表时间:2020
期刊:江苏医药
影响因子:--
作者:朱然然;吴桢珍;解卫平;刘扣英;黄茂
通讯作者:黄茂
DOI:10.1186/s13223-022-00697-9
发表时间:2022-06-19
期刊:Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
影响因子:--
作者:
通讯作者:
DOI:10.7507/1671-6205.202204066
发表时间:2022
期刊:中国呼吸与危重监护杂志
影响因子:--
作者:蒋素妹;马元;王正霞;黄茂
通讯作者:黄茂
LincR-PPP2R5C靶向调控ARNT/PP2A/STAT3和吸附miRNA介导Th2细胞分化参与支气管哮喘发生发展
  • 批准号:
    81770031
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2017
  • 负责人:
    黄茂
  • 依托单位:
国内基金
海外基金